ESG data

Governance

*The numbers of the Astellas Pharma, Inc. Board of Directors are as of the end of each fiscal year.

  UnitFY 2022FY 2023FY 2024
Board of Directors structureBoard of DirectorsPersons101111
Of which Outside DirectorsPersons777
Ratio of Outside Directors%706464
Of which Female DirectorsPersons333
Ratio of Female Directors%302745

Number in meetings of 
the Board of Directors

Number141314

Average Rate of Outside 
Directors’ attendance in 
meetings of the Board of 
Directors

%989998
Audit & Supervisory
Committee structure
Audit & Supervisory
Committee Members
Persons444
Of which Outside
Directors 
Persons333
Of which Female DirectorsPersons224
Number in meetings of the
Audit & Supervisory 
Committee
Number192020
Average Rate of Outside 
Director’s attendance in 
meetings of the Audit & 
Supervisory Committee
%100100100
Nomination Committee structureChair Outside DirectorOutside DirectorOutside Director
Member of the
Nomination Committee
(including Chair)
Persons444
Of which Outside
Directors
Persons444
Number in meetings of the 
Nomination Committee
Number799

Average Rate of Outside 
Director’s attendance in
meetings of the 
Nomination Committee

%1009797
Compensation Committee structureChair Outside DirectorOutside DirectorOutside Director
Member of the
Compensation Committee
(including Chair)
Persons444
Of which Outside
Directors
Persons444
Number in meetings of the 
Compensation Committee
Number7710

Average Rate of Outside 
Director’s attendance in 
meetings of the 
Compensation Committee

%100100100

Number of Substantiated Breaches (Disclosed since FY2023)

Reporting AreasUnitFY2023
Corruption or BriberyMatters0
Conflicts of InterestMatters2
Money Laundering or Insider TradingMatters1
Discrimination or Power Harassment*Matters4

  • *This includes matters that were reported to E&C and investigated to conclusion through the global investigation process led by E&C and Legal. It does not include issues reported directly to other departments or which E&C referred to another department to handle as it deemed appropriate